The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Intrauterine Contraceptive-Global Market Insights and Sales Trends 2024
Synopsis
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
The global Intrauterine Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intrauterine Contraceptive in various end use industries. The expanding demands from the Hospitals, Community Health Care Centers and Others,, are propelling Intrauterine Contraceptive market. Nonhormonal Intrauterine Contraceptive Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormonal Intrauterine Contraceptive Devices segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intrauterine Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intrauterine Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intrauterine Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intrauterine Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intrauterine Contraceptive covered in this report include DKT International, Melbea AG, Pregna International Limited, Ocon Medical Ltd, SMB Corporation of India and Mona Lisa N.V., etc.
The global Intrauterine Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation of India
Mona Lisa N.V.
Global Intrauterine Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intrauterine Contraceptive market, Segment by Type:
Nonhormonal Intrauterine Contraceptive Devices
Hormonal Intrauterine Contraceptive Devices
Global Intrauterine Contraceptive market, by Application
Hospitals
Community Health Care Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intrauterine Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intrauterine Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
An intrauterine contraceptive device is a medical device, which is inserted in the uterus to prevent conception. A plastic string is attached to the end of the device to ensure correct placement and its removal. These devices are available in various forms, such as coil, loop, triangle, and T-shaped, and are made up of plastic or metal. An intrauterine contraceptive device may also be used as an emergency contraception method after unprotected sex. An intrauterine contraceptive device is inserted into the uterus with the help of health care professionals.
The global Intrauterine Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Intrauterine Contraceptive in various end use industries. The expanding demands from the Hospitals, Community Health Care Centers and Others,, are propelling Intrauterine Contraceptive market. Nonhormonal Intrauterine Contraceptive Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormonal Intrauterine Contraceptive Devices segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Intrauterine Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Intrauterine Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Intrauterine Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Intrauterine Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Intrauterine Contraceptive covered in this report include DKT International, Melbea AG, Pregna International Limited, Ocon Medical Ltd, SMB Corporation of India and Mona Lisa N.V., etc.
The global Intrauterine Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DKT International
Melbea AG
Pregna International Limited
Ocon Medical Ltd
SMB Corporation of India
Mona Lisa N.V.
Global Intrauterine Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Intrauterine Contraceptive market, Segment by Type:
Nonhormonal Intrauterine Contraceptive Devices
Hormonal Intrauterine Contraceptive Devices
Global Intrauterine Contraceptive market, by Application
Hospitals
Community Health Care Centers
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Intrauterine Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Intrauterine Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Intrauterine Contraceptive Market Overview
1.1 Intrauterine Contraceptive Product Overview
1.2 Intrauterine Contraceptive Market Segment by Type
1.2.1 Nonhormonal Intrauterine Contraceptive Devices
1.2.2 Hormonal Intrauterine Contraceptive Devices
1.3 Global Intrauterine Contraceptive Market Size by Type
1.3.1 Global Intrauterine Contraceptive Market Size Overview by Type (2018-2029)
1.3.2 Global Intrauterine Contraceptive Historic Market Size Review by Type (2018-2023)
1.3.3 Global Intrauterine Contraceptive Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intrauterine Contraceptive Sales Breakdown by Type (2018-2023)
1.4.2 Europe Intrauterine Contraceptive Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Intrauterine Contraceptive Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Intrauterine Contraceptive Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Intrauterine Contraceptive Sales Breakdown by Type (2018-2023)
2 Global Intrauterine Contraceptive Market Competition by Company
2.1 Global Top Players by Intrauterine Contraceptive Sales (2018-2023)
2.2 Global Top Players by Intrauterine Contraceptive Revenue (2018-2023)
2.3 Global Top Players by Intrauterine Contraceptive Price (2018-2023)
2.4 Global Top Manufacturers Intrauterine Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intrauterine Contraceptive Market Competitive Situation and Trends
2.5.1 Intrauterine Contraceptive Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Intrauterine Contraceptive Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intrauterine Contraceptive as of 2022)
2.7 Date of Key Manufacturers Enter into Intrauterine Contraceptive Market
2.8 Key Manufacturers Intrauterine Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intrauterine Contraceptive Status and Outlook by Region
3.1 Global Intrauterine Contraceptive Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Intrauterine Contraceptive Historic Market Size by Region
3.2.1 Global Intrauterine Contraceptive Sales in Volume by Region (2018-2023)
3.2.2 Global Intrauterine Contraceptive Sales in Value by Region (2018-2023)
3.2.3 Global Intrauterine Contraceptive Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Intrauterine Contraceptive Forecasted Market Size by Region
3.3.1 Global Intrauterine Contraceptive Sales in Volume by Region (2024-2029)
3.3.2 Global Intrauterine Contraceptive Sales in Value by Region (2024-2029)
3.3.3 Global Intrauterine Contraceptive Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Intrauterine Contraceptive by Application
4.1 Intrauterine Contraceptive Market Segment by Application
4.1.1 Hospitals
4.1.2 Community Health Care Centers
4.1.3 Others
4.2 Global Intrauterine Contraceptive Market Size by Application
4.2.1 Global Intrauterine Contraceptive Market Size Overview by Application (2018-2029)
4.2.2 Global Intrauterine Contraceptive Historic Market Size Review by Application (2018-2023)
4.2.3 Global Intrauterine Contraceptive Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intrauterine Contraceptive Sales Breakdown by Application (2018-2023)
4.3.2 Europe Intrauterine Contraceptive Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Intrauterine Contraceptive Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Intrauterine Contraceptive Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Intrauterine Contraceptive Sales Breakdown by Application (2018-2023)
5 North America Intrauterine Contraceptive by Country
5.1 North America Intrauterine Contraceptive Historic Market Size by Country
5.1.1 North America Intrauterine Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Intrauterine Contraceptive Sales in Volume by Country (2018-2023)
5.1.3 North America Intrauterine Contraceptive Sales in Value by Country (2018-2023)
5.2 North America Intrauterine Contraceptive Forecasted Market Size by Country
5.2.1 North America Intrauterine Contraceptive Sales in Volume by Country (2024-2029)
5.2.2 North America Intrauterine Contraceptive Sales in Value by Country (2024-2029)
6 Europe Intrauterine Contraceptive by Country
6.1 Europe Intrauterine Contraceptive Historic Market Size by Country
6.1.1 Europe Intrauterine Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Intrauterine Contraceptive Sales in Volume by Country (2018-2023)
6.1.3 Europe Intrauterine Contraceptive Sales in Value by Country (2018-2023)
6.2 Europe Intrauterine Contraceptive Forecasted Market Size by Country
6.2.1 Europe Intrauterine Contraceptive Sales in Volume by Country (2024-2029)
6.2.2 Europe Intrauterine Contraceptive Sales in Value by Country (2024-2029)
7 Asia-Pacific Intrauterine Contraceptive by Region
7.1 Asia-Pacific Intrauterine Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Intrauterine Contraceptive Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Intrauterine Contraceptive Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Intrauterine Contraceptive Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Intrauterine Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Intrauterine Contraceptive Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Intrauterine Contraceptive Sales in Value by Region (2024-2029)
8 Latin America Intrauterine Contraceptive by Country
8.1 Latin America Intrauterine Contraceptive Historic Market Size by Country
8.1.1 Latin America Intrauterine Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Intrauterine Contraceptive Sales in Volume by Country (2018-2023)
8.1.3 Latin America Intrauterine Contraceptive Sales in Value by Country (2018-2023)
8.2 Latin America Intrauterine Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Intrauterine Contraceptive Sales in Volume by Country (2024-2029)
8.2.2 Latin America Intrauterine Contraceptive Sales in Value by Country (2024-2029)
9 Middle East and Africa Intrauterine Contraceptive by Country
9.1 Middle East and Africa Intrauterine Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Intrauterine Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Intrauterine Contraceptive Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Intrauterine Contraceptive Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Intrauterine Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Intrauterine Contraceptive Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Intrauterine Contraceptive Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 DKT International
10.1.1 DKT International Company Information
10.1.2 DKT International Introduction and Business Overview
10.1.3 DKT International Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.1.4 DKT International Intrauterine Contraceptive Products Offered
10.1.5 DKT International Recent Development
10.2 Melbea AG
10.2.1 Melbea AG Company Information
10.2.2 Melbea AG Introduction and Business Overview
10.2.3 Melbea AG Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Melbea AG Intrauterine Contraceptive Products Offered
10.2.5 Melbea AG Recent Development
10.3 Pregna International Limited
10.3.1 Pregna International Limited Company Information
10.3.2 Pregna International Limited Introduction and Business Overview
10.3.3 Pregna International Limited Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pregna International Limited Intrauterine Contraceptive Products Offered
10.3.5 Pregna International Limited Recent Development
10.4 Ocon Medical Ltd
10.4.1 Ocon Medical Ltd Company Information
10.4.2 Ocon Medical Ltd Introduction and Business Overview
10.4.3 Ocon Medical Ltd Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ocon Medical Ltd Intrauterine Contraceptive Products Offered
10.4.5 Ocon Medical Ltd Recent Development
10.5 SMB Corporation of India
10.5.1 SMB Corporation of India Company Information
10.5.2 SMB Corporation of India Introduction and Business Overview
10.5.3 SMB Corporation of India Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SMB Corporation of India Intrauterine Contraceptive Products Offered
10.5.5 SMB Corporation of India Recent Development
10.6 Mona Lisa N.V.
10.6.1 Mona Lisa N.V. Company Information
10.6.2 Mona Lisa N.V. Introduction and Business Overview
10.6.3 Mona Lisa N.V. Intrauterine Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mona Lisa N.V. Intrauterine Contraceptive Products Offered
10.6.5 Mona Lisa N.V. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intrauterine Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intrauterine Contraceptive Industrial Chain Analysis
11.4 Intrauterine Contraceptive Market Dynamics
11.4.1 Intrauterine Contraceptive Industry Trends
11.4.2 Intrauterine Contraceptive Market Drivers
11.4.3 Intrauterine Contraceptive Market Challenges
11.4.4 Intrauterine Contraceptive Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intrauterine Contraceptive Distributors
12.3 Intrauterine Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
